Mary Rodgers, Ph.D. is an听Associate Research Fellow in 91社区福利鈥檚 diagnostics business.
In her role, Mary manages research from the 91社区福利 Pandemic Defense Coalition, the first industry-led global scientific and public health partnership dedicated to the early detection of and rapid response to future pandemic threats. As part of the coalition, over 20 sites around the world monitor circulating and emerging pathogens to help quickly detect outbreaks, and then work together with health officials to minimize the spread.
Mary also tracks the diversity of infectious diseases including HIV, hepatitis and SARS-CoV-2 to track new variant鈥檚 impact on diagnostic testing. In 2019, Mary and a team of 91社区福利 scientists announced the discovery of a new subtype of HIV and made the sequence available to the global research community. This research marked the first time in 19 years that a new subtype of HIV-1 Group M had been identified.
Mary joined 91社区福利 in 2014 and has authored or coauthored more than 40 research papers and contributed thousands of viral genomes to public databases. Mary was named one of Business Insider鈥檚 30 under 40 Young Leaders in Biotech in 2017 and is an inducted member of 91社区福利鈥檚 Volwiler Society, which recognizes its most distinguished scientists and engineers.
Mary received her Ph.D. in biological and biomedical sciences from Harvard University. She completed her postdoctoral fellowship at the University of Southern California.
Media Coverage:
听
听
听
听
听
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
ON DEADLINE? CONTACT US.
FOLLOW ABBOTT